北京同仁堂2026年第一季度报告深度解析

一、业绩概览与核心看点

• 营业收入同比下降11.59%：2026年第一季度营业收入为46.64亿元，较去年同期（52.76亿元）下降了11.59%。
• 归母净利润下滑19.07%：归属于上市公司股东的净利润为4.71亿元，同比减少19.07%，扣非后净利润为4.70亿元，降幅为19.15%。
• 利润总额大幅减少24.87%：利润总额为7.48亿元，同比大降。
• 现金流逆势增长：经营活动产生的现金流量净额为9.42亿元，同比增长13.20%。
• 研发投入大幅提升：研发费用同比增长41.61%，显示公司加大创新力度。
• 投资收益大幅提升：投资收益同比增长2,438.71%，主因是结构性存款收益增加。
• 资产处置收益激增：资产处置收益同比增长11,289%，反映相关资产处置带来一次性利好。

二、影响股东和股价的重大事项

1. 业绩下滑或引发市场担忧

由于营收和净利润的双双下滑，尤其是净利润降幅接近两成，若公司无法有效提振主营业务，可能对市场信心和股价形成压力。

2. 现金流改善展现一定韧性

尽管盈利能力下降，但公司经营活动产生的现金流净额逆势增长13.2%，显示其运营现金流仍较为稳健，有望缓解短期资金压力。

3. 研发投入大幅上升

研发费用同比猛增41.61%，显示公司加大了新产品或技术研发投入。这对未来产品创新和市场拓展构成利好，但短期会加重费用压力。

4. 资产与负债结构稳定

• 总资产为310.08亿元，较年初增长1.26%。
• 归属于上市公司股东的所有者权益为140.85亿元，较年初增长3.14%。
• 负债合计约90.99亿元，较年初略有下降，资产负债结构总体稳健。

5. 非经常性损益影响有限

本期非经常性损益合计为157万元，对整体净利润影响不大，表明本期业绩下滑主要源于主营业务压力，而非一次性因素。

6. 股权结构与主要股东情况

• 公司控股股东为北京同仁堂（集团）有限责任公司，持股比例高达52.45%。
• 前十大股东中，机构投资者和保险资金占比较高，显示资本市场对公司仍有一定信心。

三、其他需投资者重点关注事项

• 应收账款同比大幅增长88.78%，主要因授予客户的信用额度增加，需留意应收账款管理及后续回款情况。
• 汇率变动导致其他综合收益下降42.62%，可能与公司海外业务相关，投资者需关注外汇风险管理。
• 投资活动现金流大幅流出，净流出额达7.78亿元，主要因结构性存款配置增加，短期影响公司流动性。
• 筹资活动现金流净流出3.22亿元，主要系偿还借款和支付利息所致。
• 期末现金及现金等价物余额降至105.16亿元，较年初有所减少。

四、结论与投资建议

本季度北京同仁堂主营业务承压，业绩下滑明显，短期内对股价形成一定压力。但公司经营现金流稳定、研发投入增加，以及资产负债结构较为健康，为中长期发展提供了基础。后续需持续关注公司主营业务恢复、应收账款管理以及创新成果转化情况。

免责声明

本文仅为信息解读，不构成任何投资建议。投资有风险，入市需谨慎。

English Translation

In-depth Analysis of Beijing Tong Ren Tang 2026 Q1 Report

1. Overview and Key Highlights

• Operating revenue down 11.59% YoY: Q1 2026 revenue was RMB 4.664 billion, down from RMB 5.276 billion a year ago.
• Net profit attributable to shareholders down 19.07%: Net profit was RMB 471 million, down 19.07% YoY, and RMB 470 million after deducting non-recurring items.
• Total profit dropped 24.87%: Total profit stood at RMB 748 million, a significant decline.
• Operating cash flow up 13.20%: Net cash from operations was RMB 942 million, up 13.2% YoY, showing resilience.
• R&D spending surged: R&D expenses jumped 41.61% YoY, reflecting increased innovation investment.
• Investment income soared: Investment income grew 2,438.71% YoY, mostly from structured deposit returns.
• Asset disposal gains surged: Asset disposal income rose 11,289% YoY, indicating significant one-off gains.

2. Key Shareholder and Price-Sensitive Information

1. Earnings Decline May Pressure Share Price

Both revenue and net profit declined sharply, especially net profit by nearly 20%. If the company fails to revive core business, market confidence and share price could be affected.

2. Operating Cash Flow Shows Resilience

Despite weaker earnings, operating cash flow increased, indicating solid cash generation to support short-term funding needs.

3. R&D Investment Substantially Increased

The 41.61% YoY jump in R&D signals a commitment to innovation, which may benefit future competitiveness but adds to short-term cost pressure.

4. Stable Asset and Liability Structure

• Total assets: RMB 31.01 billion, up 1.26% from year start.
• Shareholders’ equity: RMB 14.09 billion, up 3.14%.
• Total liabilities: RMB 9.10 billion, slightly lower than at beginning of the year.

5. Limited Impact of Non-recurring Items

Non-recurring gains were RMB 1.57 million, a minor impact, indicating the profit drop was from core operations, not one-offs.

6. Shareholding Structure

• Controlling shareholder: Beijing Tong Ren Tang Group, holding 52.45%.
• Top 10 include several institutional investors, showing capital market confidence.

3. Other Investor Focus Points

• Accounts receivable up 88.78% YoY due to increased credit to clients—watch for collection risk.
• Other comprehensive income down 42.62% mainly due to FX translation—monitor FX risks.
• Investment cash outflow surged to RMB 778 million, mainly for structured deposits—may affect liquidity.
• Financing cash outflow was RMB 322 million, mostly for debt repayment and interest.
• Ending cash and equivalents at RMB 10.52 billion, down from the start of the year.

4. Conclusion and Investment Outlook

Beijing Tong Ren Tang saw significant pressure on its core business in Q1, with notable declines in revenue and profit, likely to weigh on the share price in the short term. However, resilient operating cash flows, increased R&D, and a healthy asset-liability structure provide some support for medium- to long-term outlook. Investors should keep an eye on the company’s business recovery, receivables management, and R&D outcome realization.

Disclaimer

This article is for information purposes only and does not constitute investment advice. Investing involves risk; please proceed with caution.

View 同仁堂 Historical chart here